Montanaro Asset Management Ltd reduced its holdings in Exponent, Inc. (NASDAQ:EXPO – Free Report) by 6.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 168,300 shares of the business services provider’s stock after selling 11,200 shares during the period. Exponent makes up 3.1% of Montanaro Asset Management Ltd’s holdings, making the stock its 12th biggest position. Montanaro Asset Management Ltd owned 0.33% of Exponent worth $14,996,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently bought and sold shares of EXPO. Westside Investment Management Inc. purchased a new position in Exponent in the 3rd quarter worth approximately $26,000. Private Trust Co. NA lifted its position in Exponent by 129.8% during the fourth quarter. Private Trust Co. NA now owns 278 shares of the business services provider’s stock worth $25,000 after buying an additional 157 shares in the last quarter. Atala Financial Inc purchased a new position in Exponent during the fourth quarter worth approximately $25,000. Tortoise Investment Management LLC boosted its stake in Exponent by 76.7% during the fourth quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider’s stock worth $39,000 after buying an additional 191 shares during the last quarter. Finally, Trust Co. of Vermont purchased a new stake in Exponent in the 4th quarter valued at $45,000. 92.37% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Exponent
In other Exponent news, VP Richard Reiss sold 1,736 shares of Exponent stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total value of $149,174.48. Following the sale, the vice president now owns 1,800 shares in the company, valued at $154,674. The trade was a 49.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 2.10% of the stock is currently owned by insiders.
Exponent Stock Up 0.4 %
Exponent (NASDAQ:EXPO – Get Free Report) last issued its earnings results on Thursday, February 6th. The business services provider reported $0.46 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same quarter in the prior year, the firm earned $0.41 EPS. As a group, equities analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.
About Exponent
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles
- Five stocks we like better than Exponent
- Election Stocks: How Elections Affect the Stock Market
- Energy Transfer: Powering Data With Dividends and Diversification
- What is a SEC Filing?
- Qualcomm Stock Is Coiling for a Breakout
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.